Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson's disease pathology

Neurochemistry International

Volumn 75, Issue , 2014, Pages 1-10

  Thakur, Poonam ^a   Nehru, Bimla ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Apoptosis; GSH; Heat shock proteins; Parkinson's disease; Protein aggregation; Sodium salicylate

Indexed keywords

ALPHA SYNUCLEIN; CASPASE 3; CASPASE 9; GLUTATHIONE; GLUTATHIONE DISULFIDE; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK TRANSCRIPTION FACTOR 1; PROTEASOME; ROTENONE; SALICYLATE SODIUM; UBIQUITIN; HEAT SHOCK PROTEIN 70; NERVE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG INDUCED DISEASE; ENZYME INDUCTION; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; WEIGHT CHANGE; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMAL; BODY WEIGHT; METABOLISM; OXIDATION REDUCTION REACTION; SPRAGUE DAWLEY RAT;

ALPHA-SYNUCLEIN; ANIMALS; BODY WEIGHT; GLUTATHIONE; HSP70 HEAT-SHOCK PROTEINS; MALE; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; PARKINSON DISEASE; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; ROTENONE; SODIUM SALICYLATE; UBIQUITIN;

EID: 84901777989     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2014.05.002     Document Type: Article

References (43)

1. J.K. Andersen Oxidative stress in neurodegeneration cause or consequence Nat. Rev. Neurosci. 5 2004 S18 S25
2. P. Aridon, F. Geraci, G. Turturici, M. D'Amelio, G. Savettieri, and G. Sconzo Protective role of heat shock proteins in Parkinson's disease Neurodegener. Dis. 8 4 2011 155 168
3. P.K. Auluck, H.Y. Chan, J.Q. Trojanowski, V.M. Lee, and N.M. Bonini Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease Science 295 2002 865 868 (Pubitemid 34118369)
4. A. Ayala, J.L. Venero, J. Cano, and A. Machado Mitochondrial toxins and neurodegenerative diseases Front. Biosci. 12 2007 986 1007 (Pubitemid 46846872)
5. G.E. Barreto, J. Gonzalez, F. Capani, and L. Morales Role of astrocytes in neurodegenerative diseases R.C.C. Chang, Neurodegenerative Diseases - Processes Prevention Protection and Monitoring 2011 Intechopen 485 486 ISBN, Available from http://www.intechopen.com
6. E. Carrasco, and P. Werner Selective destruction of dopaminergic neurons by low concentrations of 6-OHDA and MPP+, protection by acetylsalicylic acid (aspirin) Parkinsonism Relat. Disord. 8 2002 407 411 (Pubitemid 36151656)
7. C. Cook, and L. Petrucelli A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease Biochim. Biophys. Acta 1792 7 2009 664 675
8. M.R. Cookson Alpha-synuclein and neuronal cell death Mol. Neurodegener. 4 2009 9
9. W. Dauer, and S. Przedborski Parkinson's disease mechanisms and models Neuron 39 6 2003 889 909
10. R.J. Dinis-Oliveira, C. Sousa, F. Remião, J.A. Duarte, R. Ferreira, A. Sánchez Navarro, M.L. Bastos, and F. Carvalho Sodium salicylate prevents paraquat-induced apoptosis in the rat lung Free Radic. Biol. Med. 43 1 2007 48 61 (Pubitemid 46874835)
11. G.L. Ellman Tissue sulphydryl groups Arch. Biochem. Biophys. 82 1959 70 77
12. B. Ferger, P. Teismann, C.D. Earl, K. Kuschinsky, and W.H. Oertel Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice Naunyn-Schmiedeberg's Arch. Pharmacol. 360 1999 256 261 (Pubitemid 29480915)
13. M.C. Haigis, and B.A. Yankner The aging stress response Mol. Cell 40 2010 333 344
14. E.C. Hirsch, S. Vyas, and S. Hunot Neuroinflammation in Parkinson's disease Parkinsonism Relat. Disord. 18 Suppl. 1 2012 S210 S212
15. K. Ishihara, K. Horiguchi, N. Yamagishi, and T. Hatayama Identification of sodium salicylate as an hsp inducer using a simple screening system for stress response modulators in mammalian cells Eur. J. Biochem. 270 16 2003 3461 3468 (Pubitemid 37011639)
16. D.A. Jurivich, C. Pachetti, L. Qiu, and J.F. Welk Salicylate triggers heat shock factor differently than heat J. Biol. Chem. 270 41 1995 24489 24495
17. D.A. Jurivich, L. Sistonen, R.A. Kroes, and R.I. Morimoto Effect of sodium salicylate on the human heat shock response Science 255 5049 1992 1243 1245
18. Y. Kitamura, and Y. Nomura Stress proteins and glial functions possible therapeutic targets for neurodegenerative disorders Pharmacol. Ther. 97 1 2003 35 53 (Pubitemid 35477803)
19. J. Klucken, Y. Shin, E. Masliah, B.T. Hyman, and P.J. McLean Hsp70 reduces alpha-synuclein aggregation and toxicity J. Biol. Chem. 279 2004 25497 25502 (Pubitemid 38756808)
20. H.J. Lee, C. Kim, and S.J. Lee Alpha-synuclein stimulation of astrocytes potential role for neuroinflammation and neuroprotection Oxid. Med. Cell. Longev. 3 4 2010 283 287
21. G.R. Luo, S. Chen, and W.D. Le Are heat shock proteins therapeutic target for Parkinson's disease? Int. J. Biol. Sci. 3 1 2007 20 26 (Pubitemid 46155761)
22. M. Marí, A. Morales, A. Colell, C. García-Ruiz, and J.C. Fernández-Checa Mitochondrial glutathione a key survival antioxidant Antioxid. Redox Signal. 11 11 2009 2685 2700
23. H.L. Martin, and P. Teismann Glutathione - a review on its role and significance in Parkinson's disease FASEB J. 23 10 2009 3263 3272
24. P.J. Mclean Cellular and molecular mechanisms underlying Parkinson's disease the role of molecular chaperones A.A. Alexzander, I.R. Brown, Heat Shock Proteins and the Brain Implications for Neurodegenerative Diseases and Neuroprotection 2008 Springer New York 51 68
25. K.S. McNaught, and P. Jenner Proteasomal function is impaired in substantia nigra in Parkinson's disease Neurosci. Lett. 297 2001 191 194 (Pubitemid 32011306)
26. K.P. Mohanakumar, D. Muralikrishnan, and B. Thomas Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity Brain Res. 864 2 2000 281 290 (Pubitemid 30235109)
27. D.J. Moore, A.B. West, V.L. Dawson, M. Ted, and T.M. Dawson Molecular pathophysiology of Parkinson's disease Annu. Rev. Neurosci. 28 2005 57 87 (Pubitemid 41098899)
28. D.W. Neef, A.M. Jaeger, and D.J. Thiele Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases Nat. Rev. Drug Discov. 10 12 2011 930 944
29. B. Nehru, R. Verma, P. Khanna, and S.K. Sharma Behavioral alterations in rotenone model of Parkinson's disease attenuation by co-treatment of centrophenoxine Brain Res. 12011 2008 122 127
30. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates - The New Coronal Set 2004 Academic Press San Diego
31. A.G.E. Pearse Histochemical Theoretical and Applied 1968 Churchill Livingstone London
32. P.M. Rappold, and K. Tieu Astrocytes and therapeutics for Parkinson's disease Neurotherapeutics 7 4 2010 413 423
33. G. Ricci, L. Volpi, L. Pasquali, L. Petrozzi, and G. Siciliano Astrocyte-neuron interactions in neurological disorders J. Biol. Phys. 35 4 2009 317 336
34. K. Sairam, K.S. Saravanan, R. Banerjee, and K.P. Mohanakumar Nonsteroidal anti-inflammatory drug sodium salicylate but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats Brain Res. 966 2003 245 252 (Pubitemid 36255587)
35. R.A. Stetler, Y. Gao, A.P. Signore, G. Cao, and J. Chen HSP27: mechanisms of cellular protection against neuronal injury Curr. Mol. Med. 9 7 2009 863 872
36. A. Surguchov Molecular and cellular biology of synucleins Int. Rev. Cell Mol. Biol. 270 2008 225 317
37. A. Surguchov Synucleins: are they two-edged swords? J. Neurosci. Res. 91 2 2013 161 166
38. M. Takalo, A. Salminen, H. Soininen, M. Hiltunen, and A. Haapasalo Protein aggregation and degradation mechanisms in neurodegenerative diseases Am. J. Neurodegener. Dis. 2 1 2013 1 14
39. P. Thakur, and B. Nehru Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease Neuroscience 12 231 2013 420 431
40. W.L. Zahler, and W.W. Cleland A specific and sensitive assay for disulfides J. Biol. Chem. 243 1968 716 719
41. G.D. Zeevalk, R. Razmpour, and L.P. Bernard Glutathione and Parkinson's disease is this the elephant in the room? Biomed. Pharmacother. 62 4 2008 236 249 (Pubitemid 351626446)
42. W. Zhang, T. Wang, Z. Pei, and D.S. Miller Alpha synuclein activates microglia a process leading to disease progression in Parkinson's disease FASEB J. 19 6 2005 533 542 (Pubitemid 40471244)
43. A. Zourlidou, M.D. PayneSmith, and D.S. Latchman HSP27 but not HSP70 has a potent protective effect against alpha-synuclein-induced cell death in mammalian neuronal cells J. Neurochem. 88 6 2004 1439 1448 (Pubitemid 38366920)